Healthcare provider profile · identity verified

Dennis Starr, MD

Internal Medicine · KINGSPORT, TN · NPI 1477727816

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	359	30
Levothyroxine Sodium	Levothyroxine Sodium	346	34
Trazodone Hcl	Trazodone Hcl	325	35
Pantoprazole Sodium	Pantoprazole Sodium	300	35
Furosemide	Furosemide	295	46
Atorvastatin Calcium	Atorvastatin Calcium	279	42
Quetiapine Fumarate	Quetiapine Fumarate	228	24
Metoprolol Tartrate	Metoprolol Tartrate	201	29
Tamsulosin Hcl	Tamsulosin Hcl	196	24
Omeprazole	Omeprazole	174	20
Escitalopram Oxalate	Escitalopram Oxalate	160	19
Divalproex Sodium	Divalproex Sodium	152	21
Memantine Hcl	Memantine Hcl	147	17
Mirtazapine	Mirtazapine	141	20
Buspirone Hcl	Buspirone Hcl	139	14
Sertraline Hcl	Sertraline Hcl	133	23
Clopidogrel	Clopidogrel Bisulfate	130	13
Amlodipine Besylate	Amlodipine Besylate	129	21
Lisinopril	Lisinopril	123	22
Donepezil Hcl	Donepezil Hcl	120	21
Levetiracetam	Levetiracetam	112	suppressed
Dilt-Xr	Diltiazem Hcl	107	suppressed
Pravastatin Sodium	Pravastatin Sodium	107	suppressed
Prednisone	Prednisone	104	13
Xarelto	Rivaroxaban	104	suppressed
Duloxetine Hcl	Duloxetine Hcl	99	suppressed
Carvedilol	Carvedilol	97	15
Potassium Chloride	Potassium Chloride	95	21
Rosuvastatin Calcium	Rosuvastatin Calcium	91	18
Olanzapine	Olanzapine	84	suppressed
Metoprolol Succinate	Metoprolol Succinate	75	14
Fluoxetine Hcl	Fluoxetine Hcl	74	suppressed
Famotidine	Famotidine	73	11
Losartan Potassium	Losartan Potassium	72	18
Citalopram Hbr	Citalopram Hydrobromide	68	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	65	suppressed
Paroxetine Hcl	Paroxetine Hcl	62	suppressed
Metformin Hcl	Metformin Hcl	57	12
Spironolactone	Spironolactone	56	suppressed
Baclofen	Baclofen	48	suppressed
Risperidone	Risperidone	46	suppressed
Tradjenta	Linagliptin	45	suppressed
Fenofibrate	Fenofibrate	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	17
Jardiance	Empagliflozin	41	suppressed
Metformin Hcl Er	Metformin Hcl	41	suppressed
Meloxicam	Meloxicam	40	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Bupropion Hcl Sr	Bupropion Hcl	35	suppressed
Sodium Chloride	0.9 % Sodium Chloride	35	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Lamotrigine	Lamotrigine	33	suppressed
Ranolazine Er	Ranolazine	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Estradiol	Estradiol	31	suppressed
Klor-Con 10	Potassium Chloride	27	suppressed
Promethazine Hcl	Promethazine Hcl	27	20
Finasteride	Finasteride	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Novolog Flexpen	Insulin Aspart	24	suppressed
Nystatin	Nystatin	24	16
Rivastigmine	Rivastigmine Tartrate	24	suppressed
Torsemide	Torsemide	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Valsartan	Valsartan	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Gabapentin	Gabapentin	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Vilazodone Hcl	Vilazodone Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Cefdinir	Cefdinir	16	13
Methotrexate	Methotrexate Sodium	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	14
Ondansetron Hcl	Ondansetron Hcl	15	11
Trulicity	Dulaglutide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Imipramine Hcl	Imipramine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Meropenem	Meropenem	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	11	11
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Atenolol	Atenolol	11	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Lactulose	Lactulose	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error